€2.42
First-line combination of dasatinib and Peg-IFNα2b in chronic phase CML
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Reviews
There are no reviews yet.